Every day over 22,000 people in the World die because of cancer.
Early diagnostics often plays the key role in cancer therapy. Many patients can be cured
if the tumor is detected on the early stage of growth.
That is why NanoThea is developing a novel effective and low cost tool for early diagnostics of solid tumors.


As Henry Ford once wished to
build a car for everybody

our mission is to give every patient
chance for a reliable and precise diagnostics and early cancer detection.


To create nanoparticle that reaches even first few tumor cells
and join forces to accelerate it to every hospital.

About Us

NanoThea is a group of full of passion scientists and business professionals.

We started as a group of scientists seeking to improve available ways to fight cancer.
In multidisciplinary mashup of biologists, chemists and process engineers we developed nanoparticles using natural materials compatible with human organism. The potential of NanoThea technology has been recognized by two VC companies. We strongly believe that our technology is the future of diagnostic oncology.

Our story

Since 2012 we started to work on nanotechnology for cancer treatment and diagnosis.
In BioMedical Engineering Laboratory, established by prof. Tomasz Ciach at Warsaw University of Technology, we developed novel nanoparticles for cancer treatment using chemotherapeutics.

As a step forward after our first adventure with encapsulating drugs inside nanoparticles we decided to create nanoparticles for cancer diagnostics. We focused our research on two methods: fluorescence and radioisotopes. With combining these two methods we are able to track on-line the fate of nanoparticle in the organism. Thanks to radioisotopes even small signal from few cancer cells is visible on the PET scan. Our ideas and attitude attracted attention of two VC companies. In September 2015, together with Giza Polish Ventures and StartVenture@Poland we founded NanoThea to commercialize the innovative tool for cancer diagnostics. Now we are working to go global with our idea.

Our team


PhD hab., Associated Professor
at Warsaw University of
Technology, specialist in the field
of Biomedical Engineering,
inventor of three products
introduced to the market,
author of more than 20 patents
and patent applications.

Tomasz Ciach
Founder, Member of Management Board

Biotechnologist, PhDc on Warsaw
University of Technology, specialist
in nano-solutions for cancer treatment.
Gathered her experience on
Bioentrepreneurship Courses
and in NanoVelos Start-up research team.

Magdalena Janczewska
Founder, CEO

Chemist, graduated from
Chemical Department of Warsaw
University of Technology.
Member of BioMedical
Engineering Laboratory
at the Faculty of Chemical
and Process Engineering WUT.

Jolanta Duszak

Biotechnologist, PhDc at Warsaw
University of Technology, member
of BioMedical Engineering
Laboratory at the Faculty of
Chemical and Process
Engineering WUT

Kamil Kopeć

PhD at Institute of Organic Chemistry, Polish Academy of Sciences (IChO, PAS); M.Sc. at Chemical Department of Warsaw University of Technology (WUT). Organic Chemist experienced in organic synthesis, supramolecular chemistry and interested in bioconjugation, biopolymer chemistry.

Grzegorz Pikus

PhD, Biochemist, graduated from Biochemistry Department of Nencki Institute of Experimental Biology, Polish Academy of Sciences, member of Bioenergetic and Biomembranes Laboratry in Nencki Institute

Jarosław Walczak

PhD in Biochemistry. Gained his scientific experience at Warsaw University of Life Sciences, University of Potsdam and Nencki Institute of Experimental Biology PAS.

Michał Szkop

Surgeon, specialized in both colorectal and bariatric surgery as well as phlebology. Worked as medical advisor in PFIZER Inc., CEO in BIOIVEST 2005 SA, a small pharmaceutical company for humans and productive animals and Vice-President for R&D in BIOLEK Ltd (BIOTON SA GROUP). Co-inventor of patent and co-author of the marketed success of the product widely used in gastroenterology.

Adam Kiciak

Biotechnologist, graduated from Chemical Department of Warsaw University of Technology. Qualified in the field of biomolecular engineering. Gathered her experience in the Institute of Biochemistry and Biophysics Polish Academy of Sciences.

Maria Pietrzak

Biotechnology Engineer, graduated from Faculty of Chemistry of Warsaw University of Technology. Participant of Master Studies at WUT on a speciality of Applied Biotechnology.

Michał Żuk

Biotechnology Engineer, graduated from Faculty of Chemistry of Warsaw University of Technology. Participant of Master Studies at WUT on a speciality of Bioengineering.

Konstancja Kopyra

Biomedical Engineer,
graduated from Mechatronic Department of Warsaw
University of Technology, Mechanical Department
of Lublin University of Technology and
Medical Department of Medical University of Lublin,

Katarzyna Partyka
Board Assistant

An entrepreneur, founder
of Internet businesses.
Experienced in setting up
new life science businesses.
Partner at Polish-Israeli
VC – Giza Polish Ventures.

Marek Borzestowski

Diplomat, a specialist in the field
of Marketing, Media Relations,
Strategic Communications and
Marketing Communications.
He served as President of the
Foundation for the Disabled
and worked as Advertising
Director of Data
Telecommunications Systems
and TV Center.

Paweł Ciach
Member of Supervisory Board

Management board member
at StartVenture@Poland,
investment professional
with experience in VC, PE
and M&A. Executive officer
at seed capital funds, investing
in Polish and international
Start-Ups. Warsaw School
of Economics graduate (MSc)
and Universiteit van Tilburg.

Piotr Pietrzak
Member of Supervisory Board


We present improved tumor targeting delivery system, carrying diagnostic radioisotope for PET or SPECT detectors.

Our technology  key features:

  • Based on safe polymer nanocarrier
  • Nanoparticles accumulate inside tumor tissue due to enhanced permeation and retention through the leaky blood vessels
  • Confirmed non-toxicity and biocompatibility
  • Universal – for various cancer cell types
  • Theranostic approach – nanoparticles for diagnostics, also with potential therapeutic use
  • Precise diagnostics exploiting radioisotopes

More details about Technology will be available immediately after patent submission.


Giza Polish Ventures

BioMedical Engineering Laboratory

StartUp Hub Poland

National Centre for Research and Development

Start Venture@Poland

Bridge Alfa

Warsaw university of technology

Contact Us

Your Name nad Surname

Your Email address


Your Message

Contact Us
Waryńskiego 1
00-645 Warsaw
VAT: PL7010520710

I am text block. Click edit button to change this text.

Project co-financed by the European Regional Development Fund under the Operational Programme Innovative Economy.